Severe COVID-19 infection: An institutional review and literature overview
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS ONE, 2024. Verfasst von Ogheneyoma Akpoviroro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: COVID-19, Hospital Mortality, Comorbidity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes.
Methods
A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality.
Results
Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States of America.
- Department of Engineering, Pennsylvania State University, State College, Pennsylvania, United States of America.
- Clinical & Translational Science Institute, Boston University, Boston, Massachusetts, United States of America.
- Department of Medicine, Mater Dei Hospital, Msida, Malta.
ORCID-Profile: Ogheneyoma Akpoviroro
Zitieren
APA
Akpoviroro, O., Sauers, N. K., Uwandu, Q., Castagne, M., Akpoviroro, O. P., Humayun, S., Mirza, W., & Woodard, J. (2024). Severe COVID-19 infection: An institutional review and literature overview. PLOS ONE. https://doi.org/10.1371/journal.pone.0304960
Vancouver
Akpoviroro O, Sauers NK, Uwandu Q, Castagne M, Akpoviroro OP, Humayun S, et al. Severe COVID-19 infection: An institutional review and literature overview. PLOS ONE. 2024. doi:10.1371/journal.pone.0304960
BibTeX
@article{Akpoviroro2024,
author = {Akpoviroro, Ogheneyoma and Sauers, Nathan Kyle and Uwandu, Queeneth and Castagne, Myriam and Akpoviroro, Oghenetejiro Princess and Humayun, Sara and Mirza, Wasique and Woodard, Jameson},
title = {Severe COVID-19 infection: An institutional review and literature overview},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304960}
}
EUVIMED